Trigger Alert: Axon Therapies $32M Series A

🚀 Battle Card: Axon Therapies

• Zoar Engelman, PhD, CEO 📧 <zoar@axontherapies.com>

• New capital from Earlybird and Santé signals strong market belief in minimally invasive heart-failure solutions – an Axon Therapies sales trigger that primes the field for rapid clinical expansion. → Source

• Scaling SAVM clinical trials to prove safety and efficacy in broader patient cohorts

• Navigating complex regulatory pathways without an implantable device precedent

• Primary: Clinical Trial Management Platform → Accelerate patient enrollment &amp; data analysis

• Expansion: Regulatory Consulting Services → Streamline FDA submissions &amp; approvals

• HQ: New York, NY

• Employees: ≈ 50

• Rev: ≈ $5 M

• Website: [axontherapies.com](https://axontherapies.com/)

🤼 Competitive Intel

• Medtronic — Medical Device R&amp;D
• Unique edge: Global manufacturing scale
• Evaluated by CEO &amp; VP R&amp;D for production capacity

• Boston Scientific — Cardiac Device Engineering
• Unique edge: Specialized electrophysiology expertise
• Evaluated by Dir. Clinical Ops for design validation

• Philips — Imaging &amp; Interventional Tech
• Unique edge: Integrated imaging–therapy platforms
• Evaluated by VP R&amp;D for system interoperability

• GE Healthcare — Diagnostics &amp; Monitoring
• Unique edge: Advanced analytics integration
• Evaluated by Dir. Clinical Ops for data-driven insights

• Edwards Lifesciences — Structural Heart Devices
• Unique edge: Proven clinical trial support
• Evaluated by CEO &amp; Regulatory Lead for trial design

✅ Do-Now Checklist

Next Step

🧠 Copy My Prompt for Personalized Cold Outreach

────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY   = ❑❑
OFFER_BRIEF   = ❑Clinical Trial Management Platform❑
PROOF_METRIC  = ❑≈ TBD❑
CTA_STYLE     = ❑quick_call❑
TONE          = ❑friendly❑

────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME        = Zoar
COMPANY     = Axon Therapies
DEPT        = Clinical Ops
SIZE        = 50
BOTTLENECK  = Scaling SAVM clinical trials
EVENT       = Series A funding
DETAIL      = Closes $32M Series A
PAIN        = Scaling SAVM clinical trials to prove safety and efficacy
SRC         = https://vcnewsdaily.com/axon-therapies/venture-capital-funding/mkcxjhbwsq
SIM_CO      = ≈ TBD
WIN_METRIC  = ≈ TBD
NEXT_SIZE   = 100
EMP_EST     = ≈ 50
REV_EST     = ≈ $5 M

────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”.

Validate any ≈ guesses via SRC.

EMAIL  (keep breaks):
Subject: 50-person Clinical Ops

Zoar—noticed your Clinical Ops team is ≈ 50.

That’s when Scaling SAVM clinical trials slows growth.

We helped ≈ TBD fix this with Clinical Trial Management Platform.

Result: ≈ TBD.  
Quick call?

PS—next bottleneck hits ≈ 100.

DM ≤45 words, TONE:
Saw your post about Closes $32M Series A — Scaling SAVM clinical trials to prove safety and efficacy.  
Clinical Trial Management Platform. ≈ TBD. Quick chat?